Investor Alert: Deadline Approaching to Join Actinium Pharmaceuticals, Inc. (ATNM) Class Action - Contact Levi & Korsinsky

  • NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=149296&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.